Investing.com - MDxHealth ADR (NASDAQ: MDXH) reported fourth quarter EPS of $-0.39, $0.18 worse than the analyst estimate of $-0.21. Revenue for the quarter came in at $19.39M versus the consensus estimate of $18.56M.
Guidance
MDxHealth ADR sees FY 2024 revenue of $79.00M-$81.00M versus the analyst consensus of $80.36M.
MDxHealth ADR's stock price closed at $3.73. It is up 10.03% in the last 3 months and up 2.67% in the last 12 months.
MDxHealth ADR saw positive EPS revisions and negative EPS revisions in the last 90 days. See MDxHealth ADR's stock price’s past reactions to earnings here.
According to InvestingPro, MDxHealth ADR's Financial Health score is "good performance".
Check out MDxHealth ADR's recent earnings performance, and MDxHealth ADR's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar